Litigation Details for FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. (E.D. Pa. 2016)
✉ Email this page to a colleague
FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. (E.D. Pa. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-03-30 |
Court | District Court, E.D. Pennsylvania | Date Terminated | 2016-11-08 |
Cause | 15:0053 Federal Trade Commission Act | Assigned To | Paul Steven Diamond |
Jury Demand | None | Referred To | |
Patents | 7,276,250 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC.
Details for FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. (E.D. Pa. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-10-20 | 119 | Endo added three patents relating to an extended-release mechanism: Nos. 7,276,250; 5,662,933; and 5,… (Id. ¶¶ 45-46.) The ’250 patent expires in 2023; the ’933 and ’456 patents expired in 2013. (Id.) …generic Lidoderm did not infringe Patent No. 5,827,529, a Teikoku patent (licensed to Endo) covering certain…acquired patents—Nos. 5,741,510; 6,096,333; and 6,096,334—only one of which (the ’510 patent) was in … drugs, different markets, different patents, different patent litigations, different agreements, different | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |